That evening, all proceeds from the play “Men come from Mars, women from Venus”, performed by Xavier Viton, will be donated to the Liryc. The price is fixed at 49 euros. Friday, May 6, there were a few places left.
Sponsorship approach
Raising funds through a show is a first for the Liryc. Usually this institute specializing in cardiac rhythmology and implanted in the Xavier-Arnozan hospital, in Pessac, puts more on gala dinners. Still, self-financing is a constraint. “Our annual operating budget is approximately 11 million euros, explains Élodie Gaillacq, communications manager. We are supported by the CHU, the university, Inria, the Region and the State, whose endowment is 5 million, but we know that it is called upon to be reduced. »
Xavier Viton in “Men are from Mars, women from Venus”.
Trianon Theater
A sponsorship initiative was therefore launched three years ago, with the aim of collecting 10 million euros by 2024. These funds are intended to help research in the fight once morest strokes (cerebral vascular accidents), heart failure and sudden cardiac death, this phenomenon which results in the interruption of the electrical current supplying the heart, and which almost cost the life of the Danish footballer Christian Eriksen last summer, during the Euro.
Professor Michel Haïssaguerre, founder of the institute, is expected to be eligible for the Nobel Prize for his discovery of a treatment for atrial fibrillation
“We are the only establishment in the world to specialize in these three pathologies, continues Élodie Gaillacq. 160 people work at Liryc, including cardiologists from the University Hospital, which allows us to maintain a direct link with the problems that affect patients. Professor Michel Haïssaguerre, founder of the institute, is also tipped to be eligible for the Nobel Prize for his discovery of a treatment for atrial fibrillation (which occurs when the electrical activity of the heart becomes irregular) used each year by more than 400,000 people worldwide.
Better detect risks
The next advances might be in the field of medical imaging, with the development of a kind of clothing that the patient would wear. It would make it possible to carry out an electrocardiogram without placing electrodes and to better detect the risks of sudden cardiac death.
